Development of CRISPR-Based Diagnostic Test for SARS-CoV-2
The objective of this project is to support the development of a portable experimental solution that uses CRISPR technology to quickly detect the SARS-CoV-2 virus at a molecular level, to be used during the global health emergency caused by the COVID-19 pandemic.

Project Detail

Country

Argentina

Project Number

AR-T1248

Approval Date

May 8, 2020

Project Status

Closed

Project Type

Technical Cooperation

Sector

HEALTH

Subsector

DISEASE PREVENTION & CONTROL

Lending Instrument

Instrumento del Fondo Multilateral de Inversiones

Lending Instrument Code

MIF

Modality

-

Facility Type

-

Environmental and Social Impact Category (ESIC)

Category C: Likely to cause minimal or no negative environmental and associated social impacts

Total Cost

USD 188,500.00

Country Counterpart Financing

USD 38,500.00

Original Amount Approved

USD 150,000.00
Financial Information
Operation Number Lending Type Reporting Currency Reporting Date Signed Date Fund Financial Instrument
ATN/ME-17978-AR Non-Sovereign Guaranteed USD - United States Dollar Multilateral Investment Fund II (MIF) - Nonreimbursable
Operation Number ATN/ME-17978-AR
  • Lending Type: Non-Sovereign Guaranteed
  • Reporting Currency: USD - United States Dollar
  • Reporting Date:
  • Signed Date:
  • Fund: Multilateral Investment Fund II (MIF) -
  • Financial Instrument: Nonreimbursable

Can’t find a document? Request information

 Implementation Phase
https://www.iadb.org/document.cfm?id=EZSHARE-188800482-2
Donors Memorandum
AR-T1248 - Plan de operaciones.pdf
Jan. 25, 2021
Spanish

Have an Environmental or Social issue related to IDB projects? File a Complaint